Yuqi Xiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuqi Xiu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Chunxun Xiao
The First Affiliated Hospital of Shantou University Medical College, Shantou, China
1 shared publicationDongli Chen
The First Affiliated Hospital of Shantou University Medical College, Shantou, China
1 shared publication- Hong Zhang
Department of Nursing, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
1 shared publication - Yanchun Wu
Office of Nursing Research Institute, The First Affiliated Hospital of Shantou University Medical College, Shantou, China
1 shared publication - Zhili Liu
Nursing Department Shantou University Mental Health Center Shantou China
1 shared publication
Latest Publications
- Open Access
- 5 February 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Integrating serum globulin into the ICF framework: a novel multidimensional predictive model for 1-year mRS outcomes in acute ischemic stroke
Background: The long-term functional prognosis after ischemic stroke (IS) plays a crucial role in rehabilitation planning, yet it remains challenging to predict in clinical practice. Existing prognostic models primarily focus on short-term outcomes and lack integration of multidimensional determinants. Although elevated serum globulin levels have been associated with acute neuroinflammation and short-term disability, their prognostic significance for 1-year functional outcomes within a comprehensive biopsychosocial framework has not yet been established. To address these gaps, this study aimed to develop and validate a multidimensional prognostic model that integrates serum globulin as a key inflammatory biomarker into the International Classification of Functioning, Disability and Health (ICF) framework of the World Health Organization (WHO), with the objective of predicting 1-year functional outcome in patients with acute ischemic stroke (AIS). Methods: This prospective study consecutively enrolled 1,562 AIS patients at a Grade A tertiary hospital from 2021 to 2023; after data cleaning and screening, 1,356 cases were included for analysis. Baseline data were collected within 1 week of hospital admission. The study cohort was randomly divided into a training set (70%, n = 949) for model development and a validation set (30%, n = 407) for internal validation. The primary outcome was the patients’ functional status assessed using the modified Rankin Scale (mRS), 1-year post-admission. Predictors significant ( p < 0.05) in univariate analysis within the training set were entered into backward stepwise multivariable logistic regression. The performance of the model was comprehensively evaluated using the area under the curve (AUC), Hosmer–Lemeshow test, calibration curve, and decision curve analysis (DCA). Results: Multivariable analysis identified six independent predictors (all p < 0.05): age, occupational status, BI, serum globulin, number of stroke episodes and NIHSS. A nomogram incorporating these predictors demonstrated excellent discrimination in both training (AUC = 0.90, 95% CI 0.88–0.93) and validation sets (AUC = 0.85, 95% CI 0.80–0.89). Calibration was good, with predicted probabilities (training: 22.23%; validation: 21.72%) closely matching the observed incidence of 22.20%, nonsignificant Hosmer–Lemeshow test results ( p > 0.05), and well-aligned calibration curves. DCA confirmed the model’s superior net benefit over “treat-all” and “treat-none” strategies across clinically relevant high-risk thresholds (20–80%) in both training and validation cohorts. Conclusions: This study successfully integrated serum globulin into the ICF framework and constructed a prognostic model for the 1-year prognosis after AIS. It enables early identification of high-risk individuals and personalized rehabilitation strategies to improve long-term recovery.
- 5 February 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Open AccessIntegrating serum globulin into the ICF framework: a novel multidimensional predictive model for 1-year mRS outcomes in acute ischemic stroke
Background: The long-term functional prognosis after ischemic stroke (IS) plays a crucial role in rehabilitation planning, yet it remains challenging to predict in clinical practice. Existing prognostic models primarily focus on short-term outcomes and lack integration of multidimensional determinants. Although elevated serum globulin levels have been associated with acute neuroinflammation and short-term disability, their prognostic significance for 1-year functional outcomes within a comprehensive biopsychosocial framework has not yet been established. To address these gaps, this study aimed to develop and validate a multidimensional prognostic model that integrates serum globulin as a key inflammatory biomarker into the International Classification of Functioning, Disability and Health (ICF) framework of the World Health Organization (WHO), with the objective of predicting 1-year functional outcome in patients with acute ischemic stroke (AIS). Methods: This prospective study consecutively enrolled 1,562 AIS patients at a Grade A tertiary hospital from 2021 to 2023; after data cleaning and screening, 1,356 cases were included for analysis. Baseline data were collected within 1 week of hospital admission. The study cohort was randomly divided into a training set (70%, n = 949) for model development and a validation set (30%, n = 407) for internal validation. The primary outcome was the patients’ functional status assessed using the modified Rankin Scale (mRS), 1-year post-admission. Predictors significant ( p < 0.05) in univariate analysis within the training set were entered into backward stepwise multivariable logistic regression. The performance of the model was comprehensively evaluated using the area under the curve (AUC), Hosmer–Lemeshow test, calibration curve, and decision curve analysis (DCA). Results: Multivariable analysis identified six independent predictors (all p < 0.05): age, occupational status, BI, serum globulin, number of stroke episodes and NIHSS. A nomogram incorporating these predictors demonstrated excellent discrimination in both training (AUC = 0.90, 95% CI 0.88–0.93) and validation sets (AUC = 0.85, 95% CI 0.80–0.89). Calibration was good, with predicted probabilities (training: 22.23%; validation: 21.72%) closely matching the observed incidence of 22.20%, nonsignificant Hosmer–Lemeshow test results ( p > 0.05), and well-aligned calibration curves. DCA confirmed the model’s superior net benefit over “treat-all” and “treat-none” strategies across clinically relevant high-risk thresholds (20–80%) in both training and validation cohorts. Conclusions: This study successfully integrated serum globulin into the ICF framework and constructed a prognostic model for the 1-year prognosis after AIS. It enables early identification of high-risk individuals and personalized rehabilitation strategies to improve long-term recovery.